+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Viability Assays Market - Global Forecast 2025-2030- Product Image
Cell Viability Assays Market - Global Forecast 2025-2030- Product Image
Sale

Cell Viability Assays Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010770
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers looking to navigate ongoing advancements in cellular health technologies are increasingly turning to robust solutions in the cell viability assays market. This sector is vital for pharmaceutical innovation, clinical diagnostics, and research efficiency, with adoption driven by integration, data integrity, and workflow scalability.

Market Snapshot: Cell Viability Assays Market

The Cell Viability Assays Market grew from USD 1.99 billion in 2024 to USD 2.22 billion in 2025. It is expected to continue growing at a CAGR of 11.46%, reaching USD 3.82 billion by 2030. Market momentum is shaped by rising demand for precise, high-throughput cellular analysis, and expanding end-use in drug development, clinical diagnostics, and custom research solutions.

Scope & Segmentation

  • Product Types: Assay kits (colorimetric, fluorometric, luminescent), instruments, and software platforms.
  • Detection Methods: Chemiluminescent, colorimetric, fluorometric using calcein AM or resazurin, and luminescent using ATP or luciferase.
  • End Users: Academic and research institutions, contract research organizations, hospitals and diagnostic centers, pharmaceutical and biotechnology companies.
  • Applications: Basic research, cell proliferation studies, cytotoxicity testing, and drug screening initiatives.
  • Regional Coverage: Americas (including United States and major states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including markets such as UK, Germany, France, and others), and Asia-Pacific (including China, India, Japan, and regional economies).
  • Company Landscape: Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Promega Corporation, PerkinElmer, Inc., Agilent Technologies, Inc., Danaher Corporation, Becton, Dickinson and Company, Corning Incorporated, Lonza Group AG.

Key Takeaways

  • Cell viability assays are crucial tools enabling drug discovery, cytotoxicity studies, and personalized medicine applications, benefitting a broad but specialized end-user base.
  • Strategic investments in automation, artificial intelligence, and cloud-based analytics are reshaping workflow integration and data reproducibility in laboratories.
  • Growing demand for miniaturized and multiplexed assay formats is encouraging the simultaneous measurement of multiple cellular parameters, thus optimizing resource and sample utilization.
  • Stakeholders are actively forming collaborations between reagent suppliers, instrument manufacturers, and technology partners to ensure streamlined workflows and interoperability.
  • Regional growth is especially dynamic in Asia-Pacific, where local manufacturing and government incentives are expanding market access and technological capability.
  • End-user priorities vary significantly by segment, with academia favoring flexibility, pharma emphasizing throughput and precision, and clinical labs seeking compliance and speed.

Tariff Impact: U.S. 2025 Adjustments and Supply Chain Evolution

New U.S. tariffs imposed in 2025 have heightened pressure on global cell viability assay supply chains. Input costs for specialized reagents and optical components are rising, prompting manufacturers to prioritize domestic production and diversify vendor sources. Research institutions and procurement teams now balance urgent inventory needs against budget limitations, leading to changes in procurement strategies and strengthened regional partnerships. These shifts are fostering a more resilient supply ecosystem and promoting strategic sourcing across geographies.

Methodology & Data Sources

Research for this report combines structured interviews with industry experts, systematic reviews of scientific literature and regulatory guidance, and competitive benchmarking of leading market players. A multi-modal approach ensures analytical rigor, data triangulation, and well-grounded insights, with cross-functional expert validation throughout.

Why This Report Matters

  • Enables strategic planning by clarifying market dynamics and emerging opportunities across product, technology, and regional dimensions in the cell viability assays market.
  • Equips leadership with actionable intelligence to mitigate supply chain risk and prioritize investment in workflow integration, automation, and AI-driven analytics.
  • Supports informed decision-making on market entry, expansion, and partnership strategies based on nuanced segmentation and evolving regulatory requirements.

Conclusion

The cell viability assays market is advancing through technological innovation, integrated workflows, and adaptable sourcing strategies. Organizations that prioritize data-driven insights, regional agility, and collaborative partnerships will maintain strong positions as market conditions evolve.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of high-throughput cell viability assays in oncology drug discovery pipelines
5.2. Integration of label-free impedance-based viability assays for real-time cellular monitoring
5.3. Emergence of 3D spheroid and organoid viability assays to better mimic in vivo environments
5.4. Increasing application of AI-driven image analysis for high-content cell viability screening workflows
5.5. Development of multiplexed fluorescence and luminescence assays for simultaneous viability and toxicity assessment
5.6. Implementation of microfluidics platforms to enable low-volume high-throughput cell viability analysis
5.7. Rising demand for standardized protocols and regulatory-compliant cell viability assay kits in clinical research
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cell Viability Assays Market, by Product Type
8.1. Introduction
8.2. Assay Kits
8.2.1. Colorimetric Kits
8.2.2. Fluorometric Kits
8.2.3. Luminescent Kits
8.3. Instruments
8.4. Software
9. Cell Viability Assays Market, by Detection Method
9.1. Introduction
9.2. Chemiluminescent
9.3. Colorimetric
9.4. Fluorometric
9.4.1. Calcein AM
9.4.2. Resazurin
9.5. Luminescent
9.5.1. ATP
9.5.2. Luciferase
10. Cell Viability Assays Market, by End User
10.1. Introduction
10.2. Academic And Research Institutions
10.3. Contract Research Organizations
10.4. Hospitals And Diagnostic Centers
10.5. Pharmaceutical And Biotechnology Companies
11. Cell Viability Assays Market, by Application
11.1. Introduction
11.2. Basic Research
11.3. Cell Proliferation Studies
11.4. Cytotoxicity Testing
11.5. Drug Screening
12. Americas Cell Viability Assays Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cell Viability Assays Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cell Viability Assays Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Merck KGaA
15.3.3. Bio-Rad Laboratories, Inc.
15.3.4. Promega Corporation
15.3.5. PerkinElmer, Inc.
15.3.6. Agilent Technologies, Inc.
15.3.7. Danaher Corporation
15.3.8. Becton, Dickinson and Company
15.3.9. Corning Incorporated
15.3.10. Lonza Group AG
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CELL VIABILITY ASSAYS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CELL VIABILITY ASSAYS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CELL VIABILITY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CELL VIABILITY ASSAYS MARKET: RESEARCHAI
FIGURE 24. CELL VIABILITY ASSAYS MARKET: RESEARCHSTATISTICS
FIGURE 25. CELL VIABILITY ASSAYS MARKET: RESEARCHCONTACTS
FIGURE 26. CELL VIABILITY ASSAYS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CELL VIABILITY ASSAYS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COLORIMETRIC KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COLORIMETRIC KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CHEMILUMINESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CHEMILUMINESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COLORIMETRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COLORIMETRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CALCEIN AM, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CALCEIN AM, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY RESAZURIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY RESAZURIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ATP, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ATP, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUCIFERASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUCIFERASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CELL PROLIFERATION STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CELL PROLIFERATION STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CYTOTOXICITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CYTOTOXICITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY DRUG SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY DRUG SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 99. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 102. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 103. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 104. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 105. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 106. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 107. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 108. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 109. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 116. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 117. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 118. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 119. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 120. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 121. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 122. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 123. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 188. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 189. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 190. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 191. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 192. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 193. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 194. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 195. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 202. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 203. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 204. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 205. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 206. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 207. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 208. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 209. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 230. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 231. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 232. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 233. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 234. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 235. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 236. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 237. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 244. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 245. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 246. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 247. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 248. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 249. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 250. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 251. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 300. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 301. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 302. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 303. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 304. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 305. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 306. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 307. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABLE 321. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 325. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 326. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 327. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2024 (USD MILLION)
TABLE 328. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2025-2030 (USD MILLION)
TABLE 329. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 330. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 331. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2018-2024 (USD MILLION)
TABLE 332. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC, 2025-2030 (USD MILLION)
TABLE 333. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2018-2024 (USD MILLION)
TABLE 334. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINESCENT, 2025-2030 (USD MILLION)
TABL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cell Viability Assays market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Promega Corporation
  • PerkinElmer, Inc.
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Corning Incorporated
  • Lonza Group AG

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.22 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.82 Billion
Compound Annual Growth Rate11.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cell Viability Assays - Global Strategic Business Report - Product Image

Cell Viability Assays - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Cell Viability Assays Market Report 2025 - Product Image

Cell Viability Assays Market Report 2025

  • Report
  • 200 Pages
  • Global
From
GST Assay Kit Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

GST Assay Kit Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Cell Cytometry Market Report 2025 - Product Image

Cell Cytometry Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Glycated Albumin Assay Market - Global Forecast 2025-2030 - Product Image

Glycated Albumin Assay Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From

About the Market

The Cell Viability Assay market is a segment of the Laboratory Testing industry that focuses on the measurement of the number of viable cells in a sample. This type of assay is used to assess the health of cells, as well as to determine the effectiveness of treatments such as drugs or radiation. Cell viability assays are used in a variety of research and clinical applications, including cancer research, stem cell research, and drug development. Cell viability assays are typically performed using a variety of techniques, such as flow cytometry, fluorescent microscopy, and colorimetric assays. These assays are used to measure the number of viable cells in a sample, as well as to assess the health of the cells. Some of the companies in the Cell Viability Assay market include Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Promega Corporation, and Agilent Technologies. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.